Deals
Novartis announces USD 5 billion share repurchase
Novartis told investors that it will be holding a USD 5 billion share buyback in the next two years. The share repurchase will start immediately, according to the Switzerland-based drugmaker.
Oaktree Capital joins China Cinda's Hong Kong IPO
American asset management firm Oaktree Capital Group was reportedly among the cornerstone investors in China Cinda Asset Management Corp's initial public offering. China Cinda is expected to launch the Hong Kong listing on Monday.
Moderna raises USD110 million to develop messenger RNA Therapeutics
US-based pharmaceutical company Moderna Therapeutics announced its completion of a new funding round worth USD110 million for the development of its messenger ribonucleic (RNA) Therapeutics.
Vena inks deal to sell Uranium assets to Azincourt Uranium
Vena Resources Inc agreed to sell its 50% stake in Minergia SAC, the company's joint venture with Cameco Global Exploration Ltd, to Azincourt Uranium Inc.




